D. Smee

发表

Inhibition of Influenza a Virus Replication by Antagonism of a PI3K-AKT-mTOR Pathway Member Identified by Gene-Trap Insertional Mutagenesis

J. Murray, Jinsong Sheng, D. Rubin, 2012, Antiviral chemistry & chemotherapy.

Anti-Influenza Virus Activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its Derivatives

D. Smee, P. Selvam, N. Murugesh, 2006, Antiviral chemistry & chemotherapy.

Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.

K. Gustafson, D. Smee, L. Gubareva, 2008, Antiviral research.

Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity

Yi Xue, Jeanne A. Stuckey, Charles M. Rice, 2015, Cell.

Potent Anti-Influenza Activity of Cyanovirin-N and Interactions with Viral Hemagglutinin

K. Gustafson, M. Boyd, D. Smee, 2003, Antimicrobial Agents and Chemotherapy.

Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells

D. Smee, D. Barnard, M. Wandersee, 2008, Biochemical and Biophysical Research Communications.

Treatment of Cowpox Virus Respiratory Infections in Mice with Ribavirin as a Single Agent or Followed Sequentially by Cidofovir

D. Smee, R. Sidwell, K. Bailey, 2000, Antiviral chemistry & chemotherapy.

Maporal Virus as a Surrogate for Pathogenic New World Hantaviruses and its Inhibition by Favipiravir

D. Smee, B. Gowen, Kristin K Buys, 2011, Antiviral chemistry & chemotherapy.

Use of distance geometry approach for the in vitro antiviral activity evaluation of N-bridgehead C-nucleosides

D. Smee, B. Kobe, T. Šolmajer, 1992 .

Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.

D. Smee, K. Nicolaou, E. B. Tarbet, 2016, Antiviral research.

In Vitro Activity of Expanded-Spectrum Pyridazinyl Oxime Ethers Related to Pirodavir: Novel Capsid-Binding Inhibitors with Potent Antipicornavirus Activity

D. Smee, S. Tucker, D. Barnard, 2004, Antimicrobial Agents and Chemotherapy.

Evaluation of imiquimod for topical treatment of vaccinia virus cutaneous infections in immunosuppressed hairless mice.

D. Smee, K. Bailey, M. Wong, 2011, Antiviral research.

Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice.

D. Smee, Steven J M Jones, D. Barnard, 2016, Antiviral research.

A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.

D. Smee, W. Ng, S. Tucker, 2014, The Journal of antimicrobial chemotherapy.

Synthesis of Tubercidin, 6-Chlorotubercidin and Related Nucleosides

S. Larson, D. Smee, R. K. Robins, 1989 .

Error-prone replication of West Nile virus caused by ribavirin.

D. Smee, V. Yamshchikov, R. Sidwell, 2005, Antiviral research.

BCX4430, a Novel Nucleoside Analog, Effectively Treats Yellow Fever in a Hamster Model

D. Smee, W. Sheridan, Y. Babu, 2014, Antimicrobial Agents and Chemotherapy.

Treatment of Lethal Vaccinia Virus Respiratory Infections in Mice with Cidofovir

D. Smee, R. Sidwell, K. Bailey, 2001, Antiviral chemistry & chemotherapy.

Recombinant Eimeria Protozoan Protein Elicits Resistance to Acute Phlebovirus Infection in Mice but Not Hamsters

D. Smee, R. Sidwell, B. Gowen, 2006, Antimicrobial Agents and Chemotherapy.

Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the replication of human herpes viruses.

D. Smee, J. Lillie, R. Sidwell, 1994, Antiviral research.

Influenza Virus H1N1 inhibition by serine protease inhibitor (serpin) antithrombin III.

D. Smee, Ralf Geiben-Lynn, B. Hurst, 2014, International trends in immunity.

The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice

D. Smee, A. Sampath, D. Barnard, 2016, Viruses.

PSI-7851, a Pronucleotide of β-d-2′-Deoxy-2′-Fluoro-2′-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication

M. Otto, D. Smee, C. Espiritu, 2010, Antimicrobial Agents and Chemotherapy.

Selective inhibition of arthropod-borne and arenaviruses in vitro by 3'-fluoro-3'-deoxyadenosine.

D. Smee, A. Van Aerschot, D. Barnard, 1992, Antiviral research.

Optimization of Novel Broad Spectrum Anti-influenza Therapeutics

Xi Chen, Clinton Maddox, William Severson, 2010 .

Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever

D. Smee, M. Mendenhall, B. Gowen, 2011, PLoS neglected tropical diseases.

Development of a New Tacaribe Arenavirus Infection Model and Its Use to Explore Antiviral Activity of a Novel Aristeromycin Analog

D. Smee, B. Gowen, E. Sefing, 2010, PloS one.

Isolation and identification of compounds from Kalanchoe pinnata having human alphaherpesvirus and vaccinia virus antiviral activity

Marc D. H. Hansen, D. Smee, F. B. Johnson, 2017, Pharmaceutical biology.

Neutralizing Viruses in Suspensions by Copper Oxide-Based Filters

Humberto H. Lara-Villegas, D. Smee, D. Barnard, 2007, Antimicrobial Agents and Chemotherapy.

Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice.

D. Smee, D. Barnard, E. B. Tarbet, 2013, Future virology.

Activity of a Phenolic Dibenzylsulfide against New World Arenavirus Infections

D. Smee, B. Gowen, J. Westover, 2013, Antiviral chemistry & chemotherapy.

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

D. Smee, D. Barnard, B. Gowen, 2009, Antiviral Research.

Combinatorial Ribavirin and Interferon Alfacon-1 Therapy of Acute Arenaviral Disease in Hamsters

D. Smee, R. Sidwell, B. Gowen, 2006, Antiviral chemistry & chemotherapy.

Novel pyrazolo[3,4-d]pyrimidine nucleoside analog with broad-spectrum antiviral activity

D. Smee, R. K. Robins, R. Smith, 1987, Antimicrobial Agents and Chemotherapy.

A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays.

D. Smee, D. Barnard, J. Roth, 2008, Antiviral research.

In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.

D. Smee, D. Barnard, Y. Kumaki, 2011, Antiviral research.

VisnaVirus as an InVitro ModelforHumanImmunodeficiency VirusandInhibition byRibavirin, Phosphonoformate,

D. Smee, K. Frank, 1987 .

Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides

D. Smee, R. Smith, K. Frank, 1987, Antimicrobial Agents and Chemotherapy.

Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812).

D. Smee, R. Sidwell, K. Bailey, 2003, Antiviral Research.

Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine

D. Smee, R. Sidwell, J. Morris, 1992, Antimicrobial Agents and Chemotherapy.

Effects of TheraMax on Influenza Virus Infections in Cell Culture and in Mice

D. Smee, B. Hurst, M. Wong, 2011, Antiviral chemistry & chemotherapy.

Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells.

D. Smee, R. Boehme, T. Matthews, 1985, Biochemical pharmacology.

Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice.

D. Smee, B. Hurst, E. B. Tarbet, 2019, Virology.

Evaluation of cell viability dyes in antiviral assays with RNA viruses that exhibit different cytopathogenic properties.

D. Smee, B. Hurst, C. Day, 2017, Journal of virological methods.

Synthesis and biological evaluation of epidithio-, epitetrathio-, and bis-(methylthio)diketopiperazines: synthetic methodology, enantioselective total synthesis of epicoccin G, 8,8'-epi-ent-rostratin B, gliotoxin, gliotoxin G, emethallicin E, and haematocin and discovery of new antiviral and antimal

E. Winzeler, Ya‐Ping Sun, D. Smee, 2012, Journal of the American Chemical Society.

Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents.

D. Smee, E. B. Tarbet, J. Julander, 2012, Antiviral research.

Efﬁcacy of Orally Administered T-705 on Lethal Avian Inﬂuenza A (H5N1) Virus Infections in Mice (cid:1)

D. Smee, D. Barnard, R. Sidwell, 2007 .

Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.

D. Smee, M. Bray, B. Gowen, 2016, Antiviral research.

T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture

D. Smee, J. Nunberg, J. C. de la Torre, 2010, Antimicrobial Agents and Chemotherapy.

Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control.

D. Smee, R. Sidwell, 2003, Antiviral research.

Exacerbation of Influenza Virus Infections in Mice by Intranasal Treatments and Implications for Evaluation of Antiviral Drugs

D. Smee, M. von Itzstein, E. B. Tarbet, 2012, Antimicrobial Agents and Chemotherapy.

A review of compounds exhibiting anti-orthopoxvirus activity in animal models

D. Smee, R. Sidwell, 2003, Antiviral research.

Identiﬁcation of Novel Antipoxviral Agents: Mitoxantrone Inhibits Vaccinia Virus Replication by Blocking Virion Assembly (cid:1)

D. Smee, S. Shuman, Hakim Djaballah, 2007 .

Pharmacodynamic Evaluation of RWJ-270201, a Novel Neuraminidase Inhibitor, in a Lethal Murine Model of Influenza Predicts Efficacy for Once-Daily Dosing

D. Smee, K. Bush, G. Drusano, 2001, Antimicrobial Agents and Chemotherapy.

Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models.

D. Smee, B. Gowen, M. Wong, 2010, Antiviral research.

Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes.

D. Smee, S. Dow, R. Sidwell, 2006, Antiviral research.

Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections.

D. Smee, M. Kende, R. Sidwell, 1994, Antiviral research.

Potential Role of Immunomodulators for Treatment of Phlebovirus Infections of Animals a

D. Smee, M. Kende, J. Huggins, 1992, Annals of the New York Academy of Sciences.

Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice

D. Smee, J. Huggins, R. Sidwell, 1991, Antiviral Research.

Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012.

D. Smee, 2013, Future virology.

Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in mice.

D. Smee, C. K. Chu, R. Sidwell, 2007, Antiviral research.

Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.

D. Smee, R. Sidwell, K. Bailey, 2001, Antiviral research.

Progress in the Discovery of Compounds Inhibiting Orthopoxviruses in Animal Models

D. Smee, 2008, Antiviral chemistry & chemotherapy.

Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice.

D. Smee, R. Sidwell, M. Wandersee, 2004, The Journal of infectious diseases.

Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.

D. Smee, R. Sidwell, K. Bailey, 2004, International journal of antimicrobial agents.

Anti‐cowpox Virus Activities of Certain Adenosine Analogs, Arabinofuranosyl Nucleosides, and 2′‐Fluoro‐arabinofuranosyl Nucleosides

D. Smee, R. Sidwell, 2004, Nucleosides, nucleotides & nucleic acids.

Comparative Effects of Cidofovir and Cyclic HPMPC on Lethal Cowpox and Vaccinia Virus Respiratory Infections in Mice

D. Smee, R. Sidwell, K. Bailey, 2003, Chemotherapy.

Effects of subcutaneous treatments with cidofovir on a vaccinia virus respiratory infection in mice

D. Smee, R. Sidwell, K. Bailey, 2003 .

Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.

D. Smee, R. Sidwell, K. Bailey, 2002, Antiviral research.

Characterization of Wild-Type and Cidofovir-Resistant Strains of Camelpox, Cowpox, Monkeypox, and Vaccinia Viruses

D. Smee, M. Bray, J. Huggins, 2002, Antimicrobial Agents and Chemotherapy.

Antiviral Activity and Mode of Action Studies of Ribavirin and Mycophenolic Acid against Orthopoxviruses in Vitro

D. Smee, M. Bray, J. Huggins, 2001, Antiviral chemistry & chemotherapy.

Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir.

D. Smee, R. Sidwell, K. Bailey, 2000, Antiviral research.

Topical Treatment of Cutaneous Vaccinia Virus Infections in Immunosuppressed Hairless Mice with Selected Antiviral Substances

D. Smee, K. Bailey, M. Wong, 2011, Antiviral chemistry & chemotherapy.

Selective cytotoxicity towards cytomegalovirus-infected cells by immunotoxins consisting of gelonin linked to anti-cytomegalovirus antibody.

D. Smee, R. Sidwell, S. Malek, 1995, Antiviral research.

9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent.

J. C. Martin, D. Smee, J. Verheyden, 1983, Journal of medicinal chemistry.

Lack of Efficacy of Aurintricarboxylic Acid and Ethacrynic Acid against Vaccinia Virus Respiratory Infections in Mice

D. Smee, B. Hurst, M. Wong, 2010, Antiviral chemistry & chemotherapy.

Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever.

D. Smee, B. Gowen, J. Westover, 2015, Antiviral research.

Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: Implications for genesis of neurodevelopmental disorders

Hao Huang, Georg Juckel, David A. Pearce, 2008, Schizophrenia Research.

Viral Infection and Abnormal Brain Development: A DNA Microarray Study

D. Smee, R. Sidwell, S. Fatemi, 2007 .

Experimental disease models of influenza virus infections: recent developments

D. Smee, R. Sidwell, 2004 .

2′‐Fluoro‐2′‐deoxycytidine is a broad‐spectrum inhibitor of bunyaviruses in vitro and in phleboviral disease mouse models

D. Smee, B. Gowen, J. Westover, 2018, Antiviral research.

Copper Oxide-Based Filters Neutralizing Viruses in Suspensions by

Humberto H. Lara-Villegas, D. Smee, R. Sidwell, 2014 .

Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.

D. Smee, E. B. Tarbet, Y. Babu, 2012, Antiviral research.

Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.

D. Smee, B. Hurst, K. Klumpp, 2010, Antiviral research.

Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model.

D. Smee, C. K. Chu, J. Morrey, 2010, Antiviral research.

Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells.

D. Smee, B. Hurst, Y. Furuta, 2009, The Journal of antimicrobial chemotherapy.

Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine.

D. Smee, C. K. Chu, R. Bowen, 2008, Antiviral research.

C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection.

D. Smee, V. Siddharthan, J. Morrey, 2008, Antiviral research.

Influenza a (H1N1) Virus Resistance to Cyanovirin-N Arises Naturally during Adaptation to Mice and by Passage in Cell Culture in the Presence of the Inhibitor

M. Boyd, D. Smee, L. Gubareva, 2007, Antiviral chemistry & chemotherapy.

Activities of Oseltamivir and Ribavirin Used Alone and in Combination against Infections in Mice with Recent Isolates of Influenza a (H1N1) and B Viruses

D. Smee, R. Sidwell, K. Bailey, 2006, Antiviral chemistry & chemotherapy.

Broad-spectrum inhibitor of viruses in the Flaviviridae family.

D. Smee, Shoukath M. Ali, J. Ojwang, 2005, Antiviral research.

Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen.

D. Smee, R. Sidwell, B. Barnett, 1993, Antiviral research.

Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice.

D. Smee, R. Sidwell, K. Bailey, 2001, International immunopharmacology.

Efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine against primary and recrudescent genital herpes simplex virus type 2 infections in guinea pigs

D. Smee, E. Fraser-Smith, T. Matthews, 1983, Antimicrobial Agents and Chemotherapy.

Effects of Combinations of Favipiravir ( T-705 ) and Oseltamivir on Influenza A ( H 1 N 1 , H 3 N 2 , and H 5 N 1 ) Virus Infections in Mice

D. Smee, K. Bailey, B. Hurst, 2017 .

Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Inﬂuenza A Virus Infections in Mice (cid:1) †

D. Smee, K. Bailey, B. Hurst, 2009 .

PSI-7851, a Pronucleotide of (cid:1) - D -2 (cid:2) -Deoxy-2 (cid:2) -Fluoro-2 (cid:2) - C -Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication (cid:1)

M. Otto, D. Smee, C. Espiritu, 2010 .

Favipiravir (T-705), a novel viral RNA polymerase inhibitor.

D. Smee, D. Barnard, B. Gowen, 2013, Antiviral research.

Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus.

D. Smee, D. Barnard, J. Morrey, 2011, Antiviral research.

A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge

D. Smee, R. Buller, J. Lantto, 2021, Antiviral research.

Comparison of three dimensional synergistic analyses of percentage versus logarithmic data in antiviral studies.

D. Smee, M. Prichard, 2017, Antiviral research.

Enhanced Efficacy of Cidofovir Combined with Vaccinia Immune Globulin in Treating Progressive Cutaneous Vaccinia Virus Infections in Immunosuppressed Hairless Mice

D. Smee, E. B. Tarbet, Ashley Dagley, 2014, Antimicrobial Agents and Chemotherapy.

Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.

D. Smee, R. Sidwell, P. Wagaman, 2001, Antiviral research.

Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza

D. Smee, R. Sidwell, 2002, Expert opinion on investigational drugs.

Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand

D. Smee, H. Cottam, D. Carson, 2007, Proceedings of the National Academy of Sciences.

Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.

D. Smee, R. Sidwell, A. Holý, 1995, Antiviral research.

Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine

J. C. Martin, D. Smee, T. Matthews, 1983, Antimicrobial Agents and Chemotherapy.

In vivo antiviral activity of 5-amino-1-methyl-3-β-D-ribofuranosyl-pyrazolo[4,3-d]pyrimidin-7(6H)-one and related guanosine analogues prepared from formycin

S. Larson, D. Smee, R. K. Robins, 1991 .

Therapy and Long-Term Prophylaxis of Vaccinia Virus Respiratory Infections in Mice with an Adenovirus-Vectored Interferon Alpha (mDEF201)

D. Smee, M. Wong, J. Ennis, 2011, PloS one.

Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment.

D. Smee, R. Sidwell, M. Wandersee, 2008, International journal of antimicrobial agents.

Intranasal Treatment of Picornavirus and Coronavirus Respiratory Infections in Rodents Using 7-Thia-8-Oxoguanosine

D. Smee, R. K. Robins, H. Alaghamandan, 1990 .

Potent anti-murine cytomegalovirus activity and reduced nephrotoxicity of ganciclovir cyclic phosphonate

D. Smee, E. J. Reist, 1996, Antimicrobial agents and chemotherapy.

Synthesis and antiherpes virus activity of phosphate and phosphonate derivatives of 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine.

J. C. Martin, D. Smee, D. McGee, 1986, Journal of medicinal chemistry.

Development of antiviral levels of ribavirin in serum and urine of orally treated rats.

R. Spendlove, D. Smee, R. Sidwell, 1981, Chemotherapy.

Synthesis and Anti-Herpetic Activity of A 2′-Fluoroarabinosyl Analog of Trifluridine

D. Smee, E. Prisbe, M. Chernow, 1988 .

Coumarins and Pyranocoumarins, Potential Novel Pharmacophores for Inhibition of Measles Virus Replication

D. Smee, D. Barnard, R. Sidwell, 2002, Antiviral chemistry & chemotherapy.

Antivirally Active Ribavirin Analogues – 4,5-disubstituted 1,2,3-triazole Nucleosides: Biological Evaluation against Certain Respiratory Viruses and Computational Modelling

T. Kulinski, D. Smee, B. Hurst, 2014, Antiviral chemistry & chemotherapy.

Antitumor and antiviral activity of synthetic alpha- and beta-ribonucleosides of certain substituted pyrimido[5,4-d]pyrimidines: a new synthetic strategy for exocyclic aminonucleosides.

S. Larson, D. Smee, R. K. Robins, 1989, Journal of medicinal chemistry.

Guanosine analogues. Synthesis of nucleosides of certain 3-substituted 6-aminopyrazolo[3,4-d]pyrimidin-4(5H)-ones as potential immunotherapeutic agents.

D. Smee, R. K. Robins, J. Anderson, 1990, Journal of medicinal chemistry.

A heterocyclic molecule with significant activity against dengue virus.

D. Smee, V. Nair, J. Julander, 2009, Bioorganic & medicinal chemistry letters.

Discovery of Novel Benzoquinazolinones and Thiazoloimidazoles, Inhibitors of Influenza H5N1 and H1N1 Viruses, from a Cell-Based High-Throughput Screen

D. Smee, C. Jonsson, D. Noah, 2011, Journal of biomolecular screening.

(-)-Carbodine: enantiomeric synthesis and in vitro antiviral activity against various strains of influenza virus including H5N1 (avian influenza) and novel 2009 H1N1 (swine flu).

D. Smee, C. K. Chu, D. Barnard, 2010, Bioorganic & medicinal chemistry letters.

A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo

R. Baric, D. Smee, M. Frieman, 2009, Virology.

Effect of Interferon-Alpha and Interferon-Inducers on West Nile Virus in Mouse and Hamster Animal Models

D. Smee, R. Sidwell, C. Day, 2004, Antiviral chemistry & chemotherapy.

Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds.

D. Smee, D. Barnard, R. Sidwell, 2002, Journal of virological methods.

Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities

D. Smee, D. Barnard, R. Sidwell, 2001, Antimicrobial Agents and Chemotherapy.

In vitro and in vivo assay systems for study of influenza virus inhibitors.

D. Smee, R. Sidwell, 2000, Antiviral research.

Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog.

D. Smee, R. Sidwell, K. Bailey, 1995, Antiviral research.

Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine. II. Characterization of induced effector cells and the mechanism of induction.

D. Smee, L. Balázs, A. Jin, 1992, Immunopharmacology and immunotoxicology.

Immunoenhancing properties and antiviral activity of 7-deazaguanosine in mice

D. Smee, G. R. Revankar, H. Cottam, 1991, Antimicrobial Agents and Chemotherapy.

Roles of interferon and natural killer cells in the antiviral activity of 7-thia-8-oxoguanosine against Semliki Forest virus infections in mice.

D. Smee, W. B. Jolley, A. Jin, 1990, Antiviral research.

Antiviral activities of 2'-deoxyribofuranosyl and arabinofuranosyl analogs of sangivamycin against retro- and DNA viruses.

D. Smee, R. K. Robins, G. R. Revankar, 1988, Antiviral research.

Inhibition of reoviruses in vitro by selected antiviral substances

R. Spendlove, D. Smee, R. Sidwell, 1981 .

Antiherpesvirus activity and mode of action of SP-303, a novel plant flavonoid.

D. Smee, R. Sidwell, J. Huffman, 1993, Chemotherapy.

Novel 3-sulphonamido-quinazolin-4(3H)-One Derivatives: Microwave-Assisted Synthesis and Evaluation of Antiviral Activities against Respiratory and Biodefense Viruses

D. Smee, D. Barnard, P. Selvam, 2007, Antiviral chemistry & chemotherapy.

Synthesis and Antiviral Activity of the 3-Deaza Analogue of 9-((1, 3-Dihydroxy-2-propoxy)Methyl)Guanine

D. Smee, D. McGee, John C. Martin, 1990 .

Antiherpes Simplex Virus Activity of 9-[4-Hydroxy-3-(hydroxymethyl)-1-butyl] guanine

D. Smee, John C. Martin, J. Verheyden, 1984 .

Synthesis and anti-herpes-virus activity of acyclic 2'-deoxyguanosine analogues related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine.

J. C. Martin, D. Smee, D. Hobbs, 1986, Journal of Medicinal Chemistry.

Synthesis and Anti-Herpes-Virus Activity of Acyclic 2′-Deoxyguanosine Analogues Related to 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine.

D. Smee, D. Hobbs, D. McGee, 1987 .

SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago).

A Brazier, D. Smee, K. Nakanishi, 1994, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge.

D. Smee, M. Bray, E. Thompson, 2000, The Journal of infectious diseases.

Comparative anti-herpesvirus activities of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, acyclovir, and two 2'-fluoropyrimidine nucleosides.

D. Smee, T. Matthews, N. Campbell, 1985, Antiviral research.

Evaluation of continuous cell lines in antiviral studies with murine cytomegalovirus

D. Smee, A. Colletti, L. B. Allen, 2005, Archives of Virology.

Lack of efficacy of AMP against recrudescent genital herpes infections in guinea pigs

D. Smee, E. Fraser-Smith, T. Matthews, 1983, Antimicrobial Agents and Chemotherapy.

The Twenty-Third International Conference on Antiviral Research

X. Chen, Y. Pommier, D. Smee, 2010, Antiviral Research.

Effect of T-705 treatment on western equine encephalitis in a mouse model.

D. Smee, J. Morrey, J. Julander, 2009, Antiviral research.

Interaction of 9-(1,3-dihydroxy-2-propoxymethyl)guanine with cytosol and mitochondrial deoxyguanosine kinases: possible role in anti-cytomegalovirus activity

D. Smee, 1985, Molecular and Cellular Biochemistry.

Identification of Novel Antipoxviral Agents: Mitoxantrone Inhibits Vaccinia Virus Replication by Blocking Virion Assembly

D. Smee, S. Shuman, Hakim Djaballah, 2007, Journal of Virology.

Identification of novel antipoxviral agents : Mitoxantrone inhibits vaccinia virus 10 replication by blocking virion assembly 11 12 13 14

D. Smee, S. Shuman, Hakim Djaballah, 2007 .

Interferon Alfacon-1 Protects Hamsters from Lethal Pichinde Virus Infection

D. Smee, D. Barnard, R. Sidwell, 2005, Antimicrobial Agents and Chemotherapy.

Spectrum of Virus Inhibition by Consensus Interferon YM643

D. Smee, R. Sidwell, J. Huffman, 2000, Antiviral chemistry & chemotherapy.

Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents.

Hong Wang, D. Smee, V. Siddharthan, 2008, Antiviral research.

Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106

D. Smee, J. Morrey, J. Julander, 2008, Antimicrobial Agents and Chemotherapy.

Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice

D. Smee, D. Barnard, R. Sidwell, 2006, Antimicrobial Agents and Chemotherapy.

Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells

D. Smee, T. Matthews, 1986, Antimicrobial Agents and Chemotherapy.

Nucleoside and nucleotide modulation of genetic expression--a new approach to chemotherapy.

D. Smee, R. K. Robins, Z. Parandoosh, 1989, Advances in enzyme regulation.

Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity

R. Spendlove, D. Smee, R. Sidwell, 1982, Antimicrobial Agents and Chemotherapy.

Antiviral activity and mode of action of ribavirin 5'-sulfamate against Semliki Forest virus.

D. Smee, R. K. Robins, G. D. Kini, 1988, Antiviral research.

In vitro and in vivo antiviral (RNA) evaluation of orotidine 5′-monophosphate decarboxylase inhibitors and analogues including 6-azauridine-5′-(ethyl methoxyalaninyl)phosphate (a 5′-monophosphate prodrug)

T. Monath, D. Smee, J. Huggins, 1994 .

Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase

D. Smee, P. Marion, W. Robinson, 1985, Antimicrobial Agents and Chemotherapy.

Identification of active antiviral compounds against a New York isolate of West Nile virus.

D. Smee, R. Sidwell, J. Morrey, 2002, Antiviral research.

Inhibition of adenovirus serotype 14 infection by octadecyloxyethyl esters of (S)‐[(3‐hydroxy‐2‐phosphonomethoxy)propyl]‐ nucleosides in vitro

D. Smee, D. Barnard, K. Hostetler, 2018, Antiviral research.

Characterization and Treatment of Cidofovir-Resistant Vaccinia (WR Strain) Virus Infections in Cell Culture and in Mice

D. Smee, R. Sidwell, M. Wandersee, 2005, Antiviral chemistry & chemotherapy.

In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegaloviruses.

D. Smee, R. Boehme, T. Matthews, 1986, Antiviral research.

Nucleotide analogs related to acyclovir and ganciclovir are effective against murine cytomegalovirus infections in BALB/c and severe combined immunodeficient mice

D. Smee, E. J. Reist, S. Sugiyama, 1994, Antimicrobial Agents and Chemotherapy.

Acyclic analogues of 2'-deoxynucleosides related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine as potential antiviral agents.

J. C. Martin, D. Smee, D. McGee, 1985, Journal of Medicinal Chemistry.

Mutations in the E9L Polymerase Gene of Cidofovir-Resistant Vaccinia Virus Strain WR Are Associated with the Drug Resistance Phenotype

D. Smee, R. Kornbluth, R. Sidwell, 2006, Antimicrobial Agents and Chemotherapy.

Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice.

D. Smee, R. Sidwell, A. Olsen, 2007, Antiviral research.

Broad-spectrum activity of 8-chloro-7-deazaguanosine against RNA virus infections in mice and rats

D. Smee, G. R. Revankar, K. Ramasamy, 1995, Antiviral Research.

Synthesis of 9-(4-hydroxy-2-oxobutyl)guanine, 9-(2,4-dihydroxybutyl)guanine and related acyclic nucleoside analogs

D. Smee, John C. Martin, J. Verheyden, 1985 .

Inhibition of orotidylate decarboxylase by 4(5H)-oxo-1-beta-D-ribofuranosylpyrazolo[3,4-d] pyrimidine-3-thiocarboxamide (APR-TC) in B lymphoblasts. Activation by adenosine kinase.

D. Smee, R. K. Robins, G. R. Revankar, 1988, Biochemical pharmacology.

Synthesis and antiherpes simplex virus activity of 9-[(1,3-dihydroxy-2-propylthio)methyl]guanine.

J. C. Martin, D. Smee, D. McGee, 1985, Journal of medicinal chemistry.

Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses

D. Smee, R. Boehme, T. Matthews, 1985, Antimicrobial Agents and Chemotherapy.

D282, a Non-Nucleoside Inhibitor of Influenza Virus Infection that Interferes with de novo Pyrimidine Biosynthesis

D. Smee, B. Hurst, C. Day, 2012, Antiviral chemistry & chemotherapy.

Nucleoside Analog with Broad-Spectrum Antiviral Activity

D. Smee, R. K. Robins, L. Deenord, 1987 .

Alkylpurines as immunopotentiating agents. Synthesis and antiviral activity of certain alkylguanines.

D. Smee, R. K. Robins, H. Cottam, 1993, Journal of medicinal chemistry.

Alkylpurines as Immunepotentiating Agents. Synthesis and Antiviral Activity of Certain Alkylguanines.

D. Smee, R. K. Robins, H. Cottam, 1994 .

Antiviral and Immunoenhancing Properties of 7-Thia-8-Oxoguanosine and Related Guanosine Analogues

D. Smee, R. K. Robins, G. R. Revankar, 1992 .

Thiazolo(4,5-d)pyrimidine Nucleosides. The Synthesis of Certain 3-β-D-Ribofuranosylthiazolo(4,5-d)pyrimidines as Potential Immunotherapeutic Agents.

S. Larson, D. Smee, R. K. Robins, 1990 .

Antiviral activity of the novel immune modulator 7-thia-8-oxoguanosine.

D. Smee, R. K. Robins, H. Cottam, 1990, Journal of biological response modifiers.

Thiazolo[4,5-d]pyrimidine nucleosides. The synthesis of certain 3-beta-D-ribofuranosylthiazolo[4,5-d]pyrimidines as potential immunotherapeutic agents.

S. Larson, D. Smee, R. K. Robins, 1990, Journal of medicinal chemistry.

Broad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent

D. Smee, R. K. Robins, H. Cottam, 1989, Antimicrobial Agents and Chemotherapy.

Biological Response Modifiers in Combination with Antivirals against Experimentally-Induced Virus Infections

D. Smee, R. K. Robins, M. Kende, 1992 .

Murine cytomegalovirus-inhibitory effects of ImuVert.

D. Smee, R. Sidwell, J. Huffman, 1993, Antiviral research.

Direct C-glycosylation of guanine analogues: the synthesis and antiviral activity of certain 7- and 9-deazaguanine C-nucleosides.

N. S. Girgis, D. Smee, R. K. Robins, 1990, Journal of medicinal chemistry.

Inhibition of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and β-D-N4-Hydroxycytidine

M. Otto, D. Smee, D. Barnard, 2004, Antiviral chemistry & chemotherapy.

Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin

D. Smee, G. Simmons, D. Barnard, 2010, Antiviral Research.

Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication in a Lethal SARS-Cov Balb/C Mouse Model by Stinging Nettle Lectin, Urtica Dioica Agglutinin (UDA)

D. Smee, D. Barnard, M. Wandersee, 2010, Antiviral Research.

Metabolism of ganciclovir and cidofovir in cells infected with drug-resistant and wild-type strains of murine cytomegalovirus.

D. Smee, R. Warren, K. Okleberry, 1997, Antiviral research.

4,6-dibenzamidopyrazolo[3,4-d]pyrimidine is a highly selective inhibitor of cytomegalovirus adsorption to cells.

D. Smee, R. K. Robins, G. R. Revankar, 1990, Antiviral research.

Synthesis and biological properties of purine and pyrimidine 5'-deoxy-5'-(dihydroxyphosphinyl)-beta-D-ribofuranosyl analogues of AMP, GMP, IMP, and CMP.

D. Smee, R. K. Robins, M. Vaghefi, 1989, Journal of medicinal chemistry.

Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection.

D. Smee, A. Torres, Corinna W. Knorr, 2006, Antiviral research.

Antiviral Activities and Phosphorylation of 5-halo-2'-Deoxyuridines and N-Methanocarbathymidine in Cells Infected with Vaccinia Virus

D. Smee, D. Barnard, B. Hurst, 2008, Antiviral chemistry & chemotherapy.

Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virus.

D. Smee, R. Glazer, Aquilur Rahman, 2007, Antiviral research.

9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)GUANINE: A NEW POTENT AND SELECTIVE ANTIHERPES AGENT

D. Smee, John C. Martin, J. Verheyden, 1983 .

Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment.

D. Smee, R. Sidwell, J. Huffman, 1991, The Journal of infectious diseases.

Rodent Cytomegaloviruses

D. Smee, R. Boehme, T. Matthews, 2022 .

ACYCLIC ANALOGS OF 2′-DEOXYNUCLEOSIDES RELATED TO 9-((1,3-DIHYDROXY-2-PROPOXY)METHYL)GUANINE AS POTENTIAL ANTIVIRAL AGENTS

D. Smee, D. McGee, John C. Martin, 1985 .

Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro

D. Smee, P. Blair, M. D. de Jong, 2010, PloS one.

In vitro and in vivo influenza virus-inhibitory effects of viramidine.

D L Barnard, D. Smee, D. Barnard, 2005, Antiviral research.

In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus

D. Smee, D. Barnard, A. Vollmer, 2014, Archives of Virology.

Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in Mice

D. Smee, K. Bailey, B. Hurst, 2009, Antimicrobial Agents and Chemotherapy.

Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on Influenza A (H5N1) Virus Infections in Cell Culture and in Mice

D. Smee, K. Bailey, B. Hurst, 2009, Antimicrobial Agents and Chemotherapy.

Innate Immune Protection against Infectious Diseases by Pulmonary Administration of a Phospholipid-Conjugated TLR7 Ligand

D. Smee, Shiyin Yao, Fitzgerald S. Lao, 2013, Journal of Innate Immunity.

A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo

D. Markovitz, D. Smee, S. King, 2020, Proceedings of the National Academy of Sciences.

Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro

D. Smee, D. Engelthaler, P. Keim, 2009, Antimicrobial Agents and Chemotherapy.

CHARACTERIZATION OF CYTOKINE INDUCTION AND EFFECTS OF Approved: ANTIVIRAL TREATMENT IN FOUR MURINE MODELS OF POXVIRUS INFECTION

D. Smee, M. Wandersee, K. Bailey, 2016 .

Development of a respiratory disease model for enterovirus D68 in 4‐week‐old mice for evaluation of antiviral therapies

D. Smee, B. Hurst, Bart Tarbet, 2019, Antiviral research.

Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones

D. Smee, R. Lesyk, P. Grellier, 2013, European Journal of Medicinal Chemistry.

Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin

D. Smee, J. Stevens, B. Gowen, 2008, PloS one.

The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses

D. Smee, Y. Kawaoka, P. Halfmann, 2016, Journal of Virology.

An M2‐V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine‐sensitive and ‐resistant influenza A viruses

W. DeGrado, D. Smee, Chunlong Ma, 2017, Antiviral research.

Human IVIG treatment in a neurological disease model for Enterovirus A71 infection in 28-day-old AG129 mice.

D. Smee, B. Hurst, E. B. Tarbet, 2023, Virology.

In vitro Activity of the Novel Pyrimidines and Their Condensed Derivatives Against Poliovirus

V. Zhirnov, D. Smee, E. Rusanov, 2019, Current Bioactive Compounds.

Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses

D. Smee, D. Barnard, M. D. de Jong, 2012, PloS one.

Selective cytotoxicity of ricin A chain immunotoxins towards murine cytomegalovirus-infected cells

D. Smee, R. Sidwell, S. Malek, 1996, Antimicrobial agents and chemotherapy.

Mutations in Influenza Virus M1 CCHH, the Putative Zinc Finger Motif, Cause Attenuation in Mice and Protect Mice against Lethal Influenza Virus Infection

D. Smee, D. Nayak, E. Hui, 2006, Journal of Virology.

Synthesis and antiviral activity of certain guanosine analogues in the thiazolo[4,5-d]pyrimidine ring system.

D. Smee, R. K. Robins, J. Anderson, 1991, Journal of medicinal chemistry.

T-705 Treatment of Late Stage Disease in an Arenaviral Hemorrhagic Fever Model:T-705 Efficacy and Reduced Toxicity Suggests a Viable Alternative to RibavirinTherapy

D. Smee, J. Stevens, B. Gowen, 2008 .

Bioassay system for determining ribavirin levels in human serum and urine.

R. Spendlove, D. Smee, R. Sidwell, 1981, Chemotherapy.

Intracellular Phosphorylation of Carbocyclic 3-Deazaadenosine, an Anti-Ebola Virus Agent

D. Smee, M. Bray, J. Huggins, 2001, Antiviral chemistry & chemotherapy.

Combination Treatment of Influenza A Virus Infections in Cell Culture and in Mice with the Cyclopentane Neuraminidase Inhibitor RWJ-270201 and Ribavirin

D. Smee, R. Sidwell, K. Bailey, 2002, Chemotherapy.

Methods for evaluation of antiviral efficacy against influenza virus infections in animal models.

D. Smee, D. Barnard, 2013, Methods in molecular biology.

In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201

D. Smee, D. Barnard, R. Sidwell, 2001, Antimicrobial Agents and Chemotherapy.

Treatment of Mannan-Enhanced Influenza B Virus Infections in Mice with Oseltamivir, Ribavirin and Viramidine

D. Smee, R. Sidwell, M. Wandersee, 2004, Antiviral chemistry & chemotherapy.

Effects of monoclonal antibody combined with ganciclovir or (S)-1-[3-hydroxy-(2-phosphonylmethoxy)-propyl]cytosine against murine cytomegalovirus infections in cell culture and in severe combined immunodeficient mice.

D. Smee, R. Sidwell, B. Barnett, 1995, Chemotherapy.

Combination of antiviral immunotoxin and ganciclovir or cidofovir for the treatment of murine cytomegalovirus infections.

D. Smee, R. Sidwell, B. Barnett, 1996, Antiviral research.

Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection

F. Hayden, D. Smee, L. Gubareva, 2006, Antimicrobial Agents and Chemotherapy.

Utilization of Alpha-1-Acid Glycoprotein Levels in the Serum as a Parameter for in Vivo Assay of Influenza Virus Inhibitors

D. Smee, D. Barnard, R. Sidwell, 2001, Antiviral chemistry & chemotherapy.

Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.

D. Smee, K. Bush, D. Barnard, 2001, Antiviral research.

Induction of Interferon-γ-Inducible Protein 10 by SARS-CoV Infection, Interferon Alfacon 1 and Interferon Inducer in Human Bronchial Epithelial Calu-3 Cells and BALB/c Mice

Jason R. Madsen, D. Smee, A. Salazar, 2010, Antiviral chemistry & chemotherapy.

Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances

R. Spendlove, D. Smee, R. Sidwell, 1981, Antimicrobial Agents and Chemotherapy.

A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response

David Baker, Andrew B. Ward, Ian A. Wilson, 2016, PLoS pathogens.

Effects of Nasal or Pulmonary Delivered Treatments with an Adenovirus Vectored Interferon (mDEF201) on Respiratory and Systemic Infections in Mice Caused by Cowpox and Vaccinia Viruses

D. Smee, B. Hurst, M. Wong, 2013, PloS one.

Analysis of the in vitro antiviral activity of certain ribonucleosides against parainfluenza virus using a novel computer aided receptor modeling procedure.

G M Crippen, A. Ghose, G. Crippen, 1989, Journal of medicinal chemistry.

Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus.

D. Smee, J. Julander, Y. Furuta, 2020, Antiviral research.

Synthesis and In Vivo antitumor and antiviral activities of 2'-deoxyribofuranosyl and arabinofuranosyl nucleosides of certain purine-6-sulfenamides, sulfinamides and sulfonamides

S. Larson, D. Smee, R. K. Robins, 1990 .

Synthesis and in vivo Antitumor and Antiviral Activities of 2′-Deoxyribofuranosyl and Arabinofuranosyl Nucleosides of Certain Purine-6-sulfenamides, -sulfinamides and -sulfonamides.

S. Larson, D. Smee, R. K. Robins, 1990 .

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

D. Smee, D. Barnard, B. Gowen, 2009, Antiviral Research.

Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on Influenza A (H5N1) Virus Infections in Cell Culture and in Mice

D. Smee, K. Bailey, B. Hurst, 2009, Antimicrobial Agents and Chemotherapy.

Interferon alfacon 1 inhibits SARS-CoV infection In human bronchial epithelial Calu-3 cells

D. Smee, D. Barnard, M. Wandersee, 2017 .

E. Winzeler, Ya‐Ping Sun, D. Smee, 2012, Journal of the American Chemical Society.